Copyright Reports & Markets. All rights reserved.

Global Ophthalmic Perfluorocarbon Liquids Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Perfluorooctane
    • 1.3.3 Perfluorodecalin
  • 1.4 Market Analysis by Specification
    • 1.4.1 Overview: Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Specification: 2021 Versus 2025 Versus 2032
    • 1.4.2 5 ml/unit
    • 1.4.3 7 ml/unit
  • 1.5 Market Analysis by Package
    • 1.5.1 Overview: Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Package: 2021 Versus 2025 Versus 2032
    • 1.5.2 Sterile Vials
    • 1.5.3 Pre-filled Syringes
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Ophthalmology Clinic
  • 1.7 Global Ophthalmic Perfluorocarbon Liquids Market Size & Forecast
    • 1.7.1 Global Ophthalmic Perfluorocarbon Liquids Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Ophthalmic Perfluorocarbon Liquids Sales Quantity (2021-2032)
    • 1.7.3 Global Ophthalmic Perfluorocarbon Liquids Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Alcon
    • 2.1.1 Alcon Details
    • 2.1.2 Alcon Major Business
    • 2.1.3 Alcon Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.1.4 Alcon Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Alcon Recent Developments/Updates
  • 2.2 Bausch + Lomb
    • 2.2.1 Bausch + Lomb Details
    • 2.2.2 Bausch + Lomb Major Business
    • 2.2.3 Bausch + Lomb Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.2.4 Bausch + Lomb Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bausch + Lomb Recent Developments/Updates
  • 2.3 BVI Medical
    • 2.3.1 BVI Medical Details
    • 2.3.2 BVI Medical Major Business
    • 2.3.3 BVI Medical Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.3.4 BVI Medical Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 BVI Medical Recent Developments/Updates
  • 2.4 Geuder AG
    • 2.4.1 Geuder AG Details
    • 2.4.2 Geuder AG Major Business
    • 2.4.3 Geuder AG Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.4.4 Geuder AG Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Geuder AG Recent Developments/Updates
  • 2.5 DORC (ZEISS)
    • 2.5.1 DORC (ZEISS) Details
    • 2.5.2 DORC (ZEISS) Major Business
    • 2.5.3 DORC (ZEISS) Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.5.4 DORC (ZEISS) Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 DORC (ZEISS) Recent Developments/Updates
  • 2.6 Alchimia srl
    • 2.6.1 Alchimia srl Details
    • 2.6.2 Alchimia srl Major Business
    • 2.6.3 Alchimia srl Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.6.4 Alchimia srl Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Alchimia srl Recent Developments/Updates
  • 2.7 Pharmpur
    • 2.7.1 Pharmpur Details
    • 2.7.2 Pharmpur Major Business
    • 2.7.3 Pharmpur Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.7.4 Pharmpur Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Pharmpur Recent Developments/Updates
  • 2.8 Toomac Ophthalmic
    • 2.8.1 Toomac Ophthalmic Details
    • 2.8.2 Toomac Ophthalmic Major Business
    • 2.8.3 Toomac Ophthalmic Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.8.4 Toomac Ophthalmic Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Toomac Ophthalmic Recent Developments/Updates
  • 2.9 Micromed srl
    • 2.9.1 Micromed srl Details
    • 2.9.2 Micromed srl Major Business
    • 2.9.3 Micromed srl Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.9.4 Micromed srl Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Micromed srl Recent Developments/Updates
  • 2.10 Biotech Healthcare Group
    • 2.10.1 Biotech Healthcare Group Details
    • 2.10.2 Biotech Healthcare Group Major Business
    • 2.10.3 Biotech Healthcare Group Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.10.4 Biotech Healthcare Group Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Biotech Healthcare Group Recent Developments/Updates
  • 2.11 Shanghai Jieshi Medical Technology
    • 2.11.1 Shanghai Jieshi Medical Technology Details
    • 2.11.2 Shanghai Jieshi Medical Technology Major Business
    • 2.11.3 Shanghai Jieshi Medical Technology Ophthalmic Perfluorocarbon Liquids Product and Services
    • 2.11.4 Shanghai Jieshi Medical Technology Ophthalmic Perfluorocarbon Liquids Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Shanghai Jieshi Medical Technology Recent Developments/Updates

3 Competitive Environment: Ophthalmic Perfluorocarbon Liquids by Manufacturer

  • 3.1 Global Ophthalmic Perfluorocarbon Liquids Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ophthalmic Perfluorocarbon Liquids Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ophthalmic Perfluorocarbon Liquids Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ophthalmic Perfluorocarbon Liquids by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ophthalmic Perfluorocarbon Liquids Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ophthalmic Perfluorocarbon Liquids Manufacturer Market Share in 2025
  • 3.5 Ophthalmic Perfluorocarbon Liquids Market: Overall Company Footprint Analysis
    • 3.5.1 Ophthalmic Perfluorocarbon Liquids Market: Region Footprint
    • 3.5.2 Ophthalmic Perfluorocarbon Liquids Market: Company Product Type Footprint
    • 3.5.3 Ophthalmic Perfluorocarbon Liquids Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ophthalmic Perfluorocarbon Liquids Market Size by Region
    • 4.1.1 Global Ophthalmic Perfluorocarbon Liquids Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ophthalmic Perfluorocarbon Liquids Average Price by Region (2021-2032)
  • 4.2 North America Ophthalmic Perfluorocarbon Liquids Consumption Value (2021-2032)
  • 4.3 Europe Ophthalmic Perfluorocarbon Liquids Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ophthalmic Perfluorocarbon Liquids Consumption Value (2021-2032)
  • 4.5 South America Ophthalmic Perfluorocarbon Liquids Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ophthalmic Perfluorocarbon Liquids Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ophthalmic Perfluorocarbon Liquids Sales Quantity by Type (2021-2032)
  • 5.2 Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Type (2021-2032)
  • 5.3 Global Ophthalmic Perfluorocarbon Liquids Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ophthalmic Perfluorocarbon Liquids Sales Quantity by Application (2021-2032)
  • 6.2 Global Ophthalmic Perfluorocarbon Liquids Consumption Value by Application (2021-2032)
  • 6.3 Global Ophthalmic Perfluorocarbon Liquids Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ophthalmic Perfluorocarbon Liquids Sales Quantity by Type (2021-2032)
  • 7.2 North America Ophthalmic Perfluorocarbon Liquids Sales Quantity by Application (2021-2032)
  • 7.3 North America Ophthalmic Perfluorocarbon Liquids Market Size by Country
    • 7.3.1 North America Ophthalmic Perfluorocarbon Liquids Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ophthalmic Perfluorocarbon Liquids Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ophthalmic Perfluorocarbon Liquids Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ophthalmic Perfluorocarbon Liquids Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ophthalmic Perfluorocarbon Liquids Market Size by Country
    • 8.3.1 Europe Ophthalmic Perfluorocarbon Liquids Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ophthalmic Perfluorocarbon Liquids Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ophthalmic Perfluorocarbon Liquids Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ophthalmic Perfluorocarbon Liquids Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ophthalmic Perfluorocarbon Liquids Market Size by Region
    • 9.3.1 Asia-Pacific Ophthalmic Perfluorocarbon Liquids Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ophthalmic Perfluorocarbon Liquids Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ophthalmic Perfluorocarbon Liquids Sales Quantity by Type (2021-2032)
  • 10.2 South America Ophthalmic Perfluorocarbon Liquids Sales Quantity by Application (2021-2032)
  • 10.3 South America Ophthalmic Perfluorocarbon Liquids Market Size by Country
    • 10.3.1 South America Ophthalmic Perfluorocarbon Liquids Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ophthalmic Perfluorocarbon Liquids Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ophthalmic Perfluorocarbon Liquids Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ophthalmic Perfluorocarbon Liquids Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ophthalmic Perfluorocarbon Liquids Market Size by Country
    • 11.3.1 Middle East & Africa Ophthalmic Perfluorocarbon Liquids Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ophthalmic Perfluorocarbon Liquids Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ophthalmic Perfluorocarbon Liquids Market Drivers
  • 12.2 Ophthalmic Perfluorocarbon Liquids Market Restraints
  • 12.3 Ophthalmic Perfluorocarbon Liquids Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ophthalmic Perfluorocarbon Liquids and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ophthalmic Perfluorocarbon Liquids
  • 13.3 Ophthalmic Perfluorocarbon Liquids Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ophthalmic Perfluorocarbon Liquids Typical Distributors
  • 14.3 Ophthalmic Perfluorocarbon Liquids Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ophthalmic Perfluorocarbon Liquids market size was valued at US$ 127 million in 2025 and is forecast to a readjusted size of US$ 189 million by 2032 with a CAGR of 6.0% during review period.
    In 2025, global Ophthalmic Perfluorocarbon Liquids production reached approximately 760 k units, with an average global market price of around US$162 per unit. Ophthalmic perfluorocarbon liquids (PFCLs) are special liquids used in ophthalmic vitreoretinal surgery. The hydrogen atoms on the carbon atoms in the molecules are replaced by fluorine atoms, which has high density and good chemical stability. During surgery, PFCLs can effectively separate the fluid and blood under the retina to help restore the normal position of the retina, especially for treating complex retinal detachment conditions. However, due to its potential intraocular toxicity, it is currently only used as a temporary vitreous filler and must be removed immediately after surgery.
    The global demand for ophthalmic perfluorocarbon liquids is anchored in accelerating population aging. According to China's National Bureau of Statistics, the proportion of citizens aged 65 and above continues to rise, driving higher incidence of age-related retinal conditions and corresponding growth in vitrectomy surgical volumes. This demographic trend provides a stable clinical demand base for perfluorocarbon liquids as temporary intraoperative tamponade agents. On the product front, early formulations based on perfluorodecalin have accumulated extensive clinical experience globally, yet concerns over purity and postoperative residue have shifted industry focus toward high-purity perfluorooctane. The U.S. FDA approved purified perfluorooctane in 1996, with multiple subsequent products entering clinical use. From a regulatory standpoint, these products are classified as Class III high-risk medical devices across major markets, subject to rigorous premarket approval and lifecycle quality management. China's NMPA issued specific registration review guidelines in 2019, while the EU REACH regulation imposes additional compliance obligations on fluorinated chemicals. Within China, provincial-level volume-based procurement initiatives are introducing price linkage mechanisms with explicit price ceilings and requirements that bids not exceed national historical lows. The procurement rules preserve clinical end-user discretion in volume allocation, meaning products lacking clinical endorsement face share erosion even after winning a bid. Upstream fluorocarbon raw material production capacity is also scaling up to strengthen supply chain autonomy. The market will continue to evolve along two principal trajectories — product-level technological upgrading and regional structural substitution — with a clear long-term direction and an increasingly defined competitive landscape.
    This report is a detailed and comprehensive analysis for global Ophthalmic Perfluorocarbon Liquids market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ophthalmic Perfluorocarbon Liquids market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Ophthalmic Perfluorocarbon Liquids market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Ophthalmic Perfluorocarbon Liquids market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Ophthalmic Perfluorocarbon Liquids market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ophthalmic Perfluorocarbon Liquids
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ophthalmic Perfluorocarbon Liquids market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, Bausch + Lomb, BVI Medical, Geuder AG, DORC (ZEISS), Alchimia srl, Pharmpur, Toomac Ophthalmic, Micromed srl, Biotech Healthcare Group, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ophthalmic Perfluorocarbon Liquids market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Perfluorooctane
    Perfluorodecalin
    Market segment by Specification
    5 ml/unit
    7 ml/unit
    Market segment by Package
    Sterile Vials
    Pre-filled Syringes
    Market segment by Application
    Hospital
    Ophthalmology Clinic
    Major players covered
    Alcon
    Bausch + Lomb
    BVI Medical
    Geuder AG
    DORC (ZEISS)
    Alchimia srl
    Pharmpur
    Toomac Ophthalmic
    Micromed srl
    Biotech Healthcare Group
    Shanghai Jieshi Medical Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ophthalmic Perfluorocarbon Liquids product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ophthalmic Perfluorocarbon Liquids, with price, sales quantity, revenue, and global market share of Ophthalmic Perfluorocarbon Liquids from 2021 to 2026.
    Chapter 3, the Ophthalmic Perfluorocarbon Liquids competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ophthalmic Perfluorocarbon Liquids breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ophthalmic Perfluorocarbon Liquids market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Perfluorocarbon Liquids.
    Chapter 14 and 15, to describe Ophthalmic Perfluorocarbon Liquids sales channel, distributors, customers, research findings and conclusion.

    Buy now